Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: The fremantle diabetes study

Stroke

Volumn 34, Issue 9, 2003, Pages 2145-2151

  Gillett, Melissa ^b   Davis, Wendy A ^b   Jackson, Denise ^b   Bruce, David G ^b   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NONE

Author keywords

Carotid artery diseases; Diabetes mellitus, non insulin dependent; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; AUSCULTATION; CAROTID ARTERY OBSTRUCTION; CLINICAL EXAMINATION; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

AGED; AUSCULTATION; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WESTERN AUSTRALIA;

EID: 0041416271     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000087360.91794.11     Document Type: Article

References (32)

1. Wolf PA, Kannel WB, Sorlie P, McNamara P. Asymptomatic carotid bruit and risk of stroke: the Framingham Study. JAMA. 1981;245: 1442-1445.
2. Wiebers DO, Whisnant JP, Sandok BA, O'Fallon WM. Prospective comparison of a cohort with asymptomatic carotid bruit and a population-based cohort without carotid bruit. Stroke. 1990;21:984-988.
3. Chambers BR, Norris JW. Outcomes in patients with asymptomatic neck bruits. N Engl J Med. 1986;315:860-865.
4. Cooperman M, Martin EW, Evans WE. Significance of asymptomatic carotid bruits. Arch Surg. 1978;113:1339-1340.
5. Gutierrez IZ, Makula PA, Gage AA. The asymptomatic carotid bruit. Am Surg. 1985;51:388-391.
6. Ellis MR, Greenhalgh RM. Management of asymptomatic carotid bruit. J Vasc Surg. 1987;5:869-873.
7. Shorr RI, Johnson KC, Wan JY, Sutton-Tyrrell K, Pahor M, Bailey JE, Applegate WB. The prognostic significance of asymptomatic carotid bruits in the elderly. J Gen Intern Med. 1998;13:86-90.
8. Kuller LH, Anderson H, Peterson D. Nationwide cerebrovascular disease morbidity survey. Stroke. 1970;1:86-99.
9. Loug S, Melamed E, Cahanc E, Carmen A. Hypertension and diabetes as risk factors in stroke patients. Stroke. 1973;4:751-759.
10. Stallones R, Dyken M, Fang HCH. Epidemiology for stroke facilities planning. Stroke. 1972;3:360-371.
11. Abbott RD, Brand FN, Kannel WB. Epidemiology and some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med. 1990;88:376-381.
12. Davis TME, Zimmett P, Davis WA, Bruce D, Fida S, Mackay I. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multiethnic Australian community: the Fremantle Diabetes Study. Diabetic Med. 2000;17:667-674.
13. Bruce DG, Davis WA, Davis TME. Glycemic control in elderly subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc. 2000;48:1449-1453.
14. Ziegler DK, Zileli T, Dick A, Sebaugh JL. Correlation of bruits over the carotid artery with angiographically demonstrated lesions. Neurology. 1971;21:860-865.
15. Sauvé JS, Thorpe KE, Sackett DL, Taylor W, Barnett HJ, Haynes RB, et al. Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? The North American Symptomatic Carotid Endarterectomy Trial. Ann Intern Med. 1994;120:633-637.
16. Hankey GJ, Warlow CP. Symptomatic carotid ischaemic events: safest and most cost effective way of selecting patients for angiography, before carotid endarterectomy. BMJ. 1990;300:1485-1491.
17. Lee TT, Solomon NA, Heidenreich PA, Oehlert J, Garber AM. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med. 1997;126:337-346.
18. Davis TME, Millns H, Stratton IM, Holman RR, Turner RC. UKPDS 29: risk factors for stroke in type 2 diabetes mellitus. Arch Intern Med. 1998;159:1097-1103.
19. Bell DSH. Stroke in the diabetic patient. Diabetologia. 1994;17:213-219.
20. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
21. Birkenhager WH, Staessen JA, Gasowski J, de Leeuw PW. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial. J Nephrol. 2000;13:232-237.
22. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
23. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321: 412-419.
24. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
25. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2000;360:7-22.
26. Barnett HJ, Meldrum HE, Eliasziw M, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. The appropriate use of carotid endarterectomy. CMAJ. 2002;166:1169-1179.
27. Benavente O, Moher D, Pham B. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ. 1998;317:1477-1480.
28. Aziz I, Lewis RJ, Baker JD, Virgilio C. Cardiac morbidity and mortality following carotid endarterectomy: the importance of diabetes and multiple Eagle risk factors. Ann Vasc Surg. 2001;15:243-246.
29. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, et al, for the HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286: 421-426.
30. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000; 160:1093-1100.
31. Fuller JH, Stevens LK, Wang S-L, and the WHO Multinational Study Group. Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001; 44(suppl 2):S54-S64.
32. Lydakis C, Lip GY. Microalbuminuria and cardiovascular risk. Quart J Med. 1998;91:381-391.